Acetohydroxamic acid
From Wikipedia, the free encyclopedia
Acetohydroxamic acid
|
|
Systematic (IUPAC) name | |
ethanehydroxamic acid | |
Identifiers | |
CAS number | |
ATC code | G04 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C2H5NO2 |
Mol. mass | 75.0666 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Acetohydroxamic acid or AHA is a urological drug. Specifically, it is a potent and irreversible inhibitor of bacterial and plant urease. The molecule is similar to urea but is not hydrolyzable by the urease enzyme. (Fishbein and Carbone, 1965)
|
|
---|---|
Acidifiers | Ammonium chloride, Calcium chloride |
Urinary antispasmodics | Darifenacin, Emepronium, Flavoxate, Meladrazine, Oxybutynin, Propiverine, Solifenacin, Terodiline, Tolterodine, Trospium |
For erectile dysfunction | Alprostadil, Apomorphine, Avanafil, Moxisylyte, Papaverine, Phentolamine, Sildenafil, Tadalafil, Udenafil, Vardenafil, Vendafidel, Yohimbine |
Other urologicals | Acetohydroxamic acid, Collagen, Dimethyl sulfoxide, Magnesium hydroxide, Phenazopyridine, Phenyl salicylate, Succinimide |
For benign prostatic hypertrophy | 5α-reductase inhibitors: Dutasteride, Finasteride Alpha blockers: Alfuzosin, Doxazosin, Tamsulosin, Terazosin |
[edit] Notes
References J Biol Chem. 1965 Jun;240:2407-14. W. Fishbein and P. Carbone